top of page
Featured Posts

GLP-1 Weight Loss Drugs and Vision Risk: What Emerging Research Is Revealing

  • 10 hours ago
  • 5 min read
Text questioning if GLP-1 weight loss drugs pose a vision risk. White background. Bottom right text: Levinson Family Chiropractic.
Emerging research examines potential vision risks associated with GLP-1 weight loss drugs.

Millions of people are turning to GLP-1 medications like Ozempic and Wegovy to lose weight quickly.


While many patients are seeing significant results on the scale, researchers are beginning to investigate potential side effects that have received far less attention. One area now drawing interest in the medical community involves possible effects on the optic nerve and vision.


While the research is still emerging, these findings are raising important questions about how rapid medication-driven weight loss may affect the body. Before starting any new medication, it is important to understand both the benefits and the potential risks.


GLP-1 weight loss drugs such as Ozempic, Wegovy, and similar medications have become some of the most talked about treatments for weight loss in recent years. Millions of people are using them to lose weight quickly. 


But as their use has exploded, researchers and regulatory agencies have begun investigating new safety concerns that patients should understand before deciding if these medications are the right approach for them.


One emerging concern involves possible effects on the optic nerve that could impact vision.


While research is still developing, this issue highlights an important question many patients are starting to ask.


Is rapid medication driven weight loss the healthiest long term strategy for the body?


A Possible Link Between GLP-1 Drugs and Optic Nerve Damage


Researchers are currently studying a condition called Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION).


This condition occurs when blood flow to the optic nerve becomes reduced, which can lead to sudden vision loss in one eye.


Recent pharmacovigilance reports and observational studies have identified a higher reporting rate of NAION in patients taking semaglutide medications, which are commonly prescribed for diabetes and weight loss.


Important points:


  • This complication appears to be rare

  • Researchers are still determining whether the medications directly cause it

  • Patients with metabolic conditions may already have underlying vascular risk factors


Because of these signals, regulatory agencies and researchers are continuing to monitor these medications closely.


Why Researchers Are Paying Attention


GLP-1 drugs work by altering several major metabolic pathways in the body.


They:


• Suppress appetite

• Slow stomach emptying

• Alter insulin signaling

• Rapidly reduce body weight


These mechanisms can be helpful in managing blood sugar and weight. However, they also create significant metabolic shifts that occur very quickly.


Researchers are investigating whether rapid metabolic changes could contribute to:


• Reduced blood flow to delicate tissues such as the optic nerve

• Vascular stress in individuals with metabolic disease

• Changes in nutrient intake due to appetite suppression


Again, these theories are still being studied, but the signals are strong enough that clinicians are paying attention.


Another Concern: Loss of Lean Muscle Mass


Another issue emerging in the research is how much muscle may be lost during GLP-1 weight loss.


Studies suggest that 25 to 40 percent of the weight lost on these medications may come from lean body mass, including skeletal muscle.


Muscle is critical for:


• Metabolic health

• Strength and mobility

• Long term weight maintenance

• Healthy aging


When weight loss occurs too quickly without proper metabolic support, muscle loss can contribute to:


• Slower metabolism

• Fatigue

• Weight regain after stopping medication


This is one reason many clinicians believe sustainable metabolic repair should always be the primary goal of weight loss programs.


The Bigger Question: What Is the Healthiest Way to Lose Weight?


While medications can have a role in certain medical situations, they often focus on forcing weight loss rather than restoring metabolic balance.


True long term health requires improving the systems that control metabolism, including:


• Hormonal signaling

• Insulin sensitivity

• inflammation levels

• nutrient balance

• nervous system regulation


When these systems improve, the body becomes more capable of maintaining a healthy weight naturally.


Many people who come to our office tell me the same thing. They want to lose weight, but they also want to feel confident that the approach they are using is actually supporting their long term health.


They are tired of extreme diets, medications, and quick fixes that promise results but leave them feeling worse over time.


The good news is that when the body’s metabolism, hormones, and nervous system begin functioning properly again, weight loss often becomes much easier and far more sustainable.


A Safer Approach: Supporting the Body’s Natural Metabolism


In our office, our weight loss programs focus on helping the body reset and function the way it was designed to.


Instead of relying on medications that force appetite suppression, we focus on strategies that support healthy metabolic function.

Our programs may include:


• Structured fasting strategies designed to improve metabolic flexibility

• Nutritional guidance to stabilize blood sugar

• metabolic detoxification support

• targeted supplementation when appropriate

• nervous system support through chiropractic care

• lifestyle strategies that promote long term metabolic health


Many patients find that when the body begins functioning properly again, weight loss occurs naturally and is much easier to maintain.


Most importantly, this approach focuses on improving overall health rather than simply forcing the number on the scale to drop.


If You Are Considering GLP-1 Weight Loss Drugs


These medications may be appropriate for certain individuals under medical supervision. However, it is important to understand both the benefits and the potential risks.


Patients should speak with their healthcare provider if they experience symptoms such as:


• sudden vision changes

• blurred vision

• dark areas in vision

• persistent nausea or digestive problems


These symptoms should always be evaluated promptly.


For many people, addressing the root causes of metabolic dysfunction may provide a safer and more sustainable path to weight loss.


Want a Natural Plan to Support Healthy Weight Loss?


If you are struggling with weight loss and want a safer, natural approach that supports your body instead of fighting against it, our office offers structured programs designed to help restore metabolic balance.


To learn more about our weight loss programs, visit:https://www.levinsonchiro.com/weight-loss


Or call our office at (330) 928-3420 to schedule a consultation.


References


Arnett DK et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. Circulation. 2019.


Blundell J et al. Semaglutide effects on appetite and energy intake in individuals with obesity. Diabetes Obes Metab. 2017.


Kaneshiro KN et al. Association between semaglutide use and nonarteritic anterior ischemic optic neuropathy. JAMA Ophthalmology. 2024.


Rubino D et al. Effect of weekly semaglutide vs placebo on weight loss in adults with overweight or obesity. STEP clinical trials. New England Journal of Medicine. 2021.


Today's Practitioner. GLP-1 Weight Loss Drugs and Optic Nerve Risks: What Clinicians and Patients Should Know. 2025.


Wilding JPH et al. Once weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine. 2021.



 
 
 

Comments


Recent Posts
  • YouTube: Dr. Levinson Wellness
instagram image
  • Instagram
  • Facebook

Levinson Family Chiropractic
646 Portage Trail
Cuyahoga Falls, OH 44221
(330) 928-3420
www.levinsonchiro.com

If you are looking for a chiropractor in Cuyahoga Falls think of us. Serving Cuyahoga Falls, Akron, Stow, Hudson, and surrounding Northeast Ohio communities.

 HOURS:

M  8:15-11:45; 2:30-5:45

  T  8:15-10:45

 W  8:15-11:45; 2:30-5:45

Th  CLOSED

  F   8:15-1:00

Sa  By appointment 8:15-10:45

bottom of page